Nuvve Formalizes Highly Dilutive Series B Preferred Stock Terms for Omnia Financing
Summary
Nuvve Holding Corp. filed the Certificate of Designation for its Series B Convertible Preferred Stock, formalizing the terms of a highly dilutive financing deal with Omnia that could convert into 120 million common shares.
Key Events
-
Series B Preferred Stock Designated
The company designated 150,000 shares of Series B Convertible Preferred Stock with a stated value of $1,000 per share, totaling $150 million in potential value.
-
Highly Dilutive Conversion Terms
The Series B Preferred Stock is convertible into common stock at $1.25 per share, potentially adding 120 million common shares to the outstanding count, representing extreme dilution.
-
Formalizes Omnia Financing
This filing formalizes a key part of the Omnia Venture Agreements, which shareholders approved on June 23, 2026, as part of a critical financing effort to address the company's financial distress.
-
Senior Ranking
The Series B Preferred Stock ranks senior to common stock in liquidation preference, but junior to Series A Preferred Stock.
Analysis
This 8-K formalizes the terms of the Series B Convertible Preferred Stock, a key component of the Omnia financing deal recently approved by shareholders. While the conversion price of $1.25 is above the current market price of $0.3141, the potential issuance of 120 million common shares from the $150 million stated value of the preferred stock represents extreme dilution for existing shareholders. This financing is critical for the company's survival, given its 'going concern' warning and Nasdaq delisting notices, but comes at a very high cost to equity.
At the time of this filing, NVVE was trading at $0.31 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3M. The 52-week trading range was $0.23 to $45.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.